Actinium Pharmaceuticals ATNM Q1 2026 Earnings Narrower Loss Beats Expectations as Development Pipeline Advances Autolus Therapeutics Q1 2026 Earnings EPS Miss Reflects Ongoing RD Investment IMPP Q1 2026 Earnings Strong EPS Beat Surprises Analysts GWH Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage SEAT Q1 2026 Earnings EPS Misses Estimates as Loss Widens More Than Expected Universal Logistics Holdings ULH Q1 2026 Earnings Significant EPS Miss Amid Revenue Uncertainty Stock Gains 34